Cargando…

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

Detalles Bibliográficos
Autores principales:	Zeng, Lei-Ping, Ge, Xing-Yi, Peng, Cheng, Tai, Wanbo, Jiang, Shibo, Du, Lanying, Shi, Zheng-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089274/ https://www.ncbi.nlm.nih.gov/pubmed/29134417 http://dx.doi.org/10.1007/s11427-017-9189-3

Ejemplares similares

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
por: Jiang, Shibo, et al.
Publicado: (2020)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
por: Du, Lanying, et al.
Publicado: (2013)

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355–359; 2020)
por: Jiang, Shibo, et al.
Publicado: (2020)

Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2
por: Jiang, Shibo, et al.
Publicado: (2020)

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Coronavirus Antibodies in Bat Biologists
por: Stockman, Lauren J., et al.
Publicado: (2008)

Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins
por: Zhou, Peng, et al.
Publicado: (2009)

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses
por: Srisutthisamphan, Kanjana, et al.
Publicado: (2022)

Longitudinal surveillance of SARS-like coronaviruses in bats by quantitative real-time PCR
por: Wang, Mei-Niang, et al.
Publicado: (2016)

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
por: Hou, Yu-xuan, et al.
Publicado: (2010)

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Du, Lanying, et al.
Publicado: (2016)

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
por: Chen, Yanjia, et al.
Publicado: (2022)

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
por: Hu, Ben, et al.
Publicado: (2017)

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
por: Shi, Juan, et al.
Publicado: (2022)

Diversity of Coronaviruses in Bats: Insights Into Origin of SARS Coronavirus
por: Lau, S.K.P., et al.
Publicado: (2008)

Geographical structure of bat SARS-related coronaviruses
por: Yu, Ping, et al.
Publicado: (2019)

Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks — Implications for coronavirus vaccine development
por: Ng, Oi-Wing, et al.
Publicado: (2016)

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
por: Xiang, Rong, et al.
Publicado: (2022)

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
por: Ge, Xing-Yi, et al.
Publicado: (2013)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
por: Menachery, Vineet D, et al.
Publicado: (2015)

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
por: Qiu, Maofeng, et al.
Publicado: (2005)

Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya
por: Tong, Suxiang, et al.
Publicado: (2009)

Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophus hipposideros) in Slovenia
por: Rihtarič, Danijela, et al.
Publicado: (2010)

SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020
por: Alkhovsky, Sergey, et al.
Publicado: (2022)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
por: Ma, Cuiqing, et al.
Publicado: (2020)

Is there antibody-dependent enhancement in SARS Coronavirus 2?
por: Kumar, Rohit, et al.
Publicado: (2020)

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
por: Wang, Ning, et al.
Publicado: (2020)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
por: Temperton, Nigel J., et al.
Publicado: (2005)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation
por: George, Parakkal Jovvian, et al.
Publicado: (2020)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients
por: Shi, Yulin, et al.
Publicado: (2004)

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
por: Wan, Yushun, et al.
Publicado: (2020)

The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2
por: Li, Tao, et al.
Publicado: (2020)

Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats
por: Hu, Dan, et al.
Publicado: (2018)

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
por: Shi, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9895f3kibtbhr4kvrpjf6e16ni